Anthony Hunt, Chief Executive Officer at REPLIGEN CORP (RGEN), sold 23,642 shares at $84.64 ($1.9M) on 2019-09-09, disclosed to the SEC on 2019-09-11.
Open-market sale of $1.9M RGEN by Chief Executive Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $81.26 | 4,131 | $336K | 17.3% |
| 2 | $81.26 | 4,131 | $336K | 17.3% |
| 3 | $82.15 | 4,926 | $405K | 20.8% |
| 4 | $82.15 | 4,926 | $405K | 20.8% |
| 5 | $83.05 | 1,751 | $145K | 7.5% |
| 6 | $83.05 | 1,751 |
| $145K |
| 7.5% |
| 7 | $84.64 | 740 | $63K | 3.2% |
| 8 | $84.64 | 740 | $63K | 3.2% |
| 9 | $86.26 | 222 | $19K | 1.0% |
| 10 | $89.27 | 288 | $26K | 1.3% |
| 11 | $90.31 | 36 | $3K | 0.2% |
| Total | $82.27 avg | 23,642 | $1.9M | 100% |
| Filing → |
| RGEN | SELL | 2025-09-11 | $7.0M | — | Filing → |
| RGEN | SELL | 2025-05-16 | $6.5M | — | Filing → |
| RGEN | SELL | 2025-03-19 | $8.1M | — | Filing → |